Lloyd’s Newsletter
Subscribe
Sign in
Share this post
Lloyd’s Newsletter
IVERMECTIN and FENBENDAZOLE Testimonial - 46 year old patient Stage 4 Breast Cancer metastatic to bone not responding to mainstream or Integrative therapy, sees massive drop in cancer blood markers
Copy link
Facebook
Email
Notes
More
IVERMECTIN and FENBENDAZOLE Testimonial - 46…
Lloyd Miller
12 hrs ago
Share this post
Lloyd’s Newsletter
IVERMECTIN and FENBENDAZOLE Testimonial - 46 year old patient Stage 4 Breast Cancer metastatic to bone not responding to mainstream or Integrative therapy, sees massive drop in cancer blood markers
Copy link
Facebook
Email
Notes
More
2
by Dr. William Makis MD
Read →
Comments
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Share this post
IVERMECTIN and FENBENDAZOLE Testimonial - 46…
Share this post
by Dr. William Makis MD